4.7 Article

The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia

期刊

LIFE SCIENCES
卷 67, 期 12, 页码 1447-1454

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0024-3205(00)00736-0

关键词

preeclampsia; nitric oxide; endothelin-1; blood; endothelial dysfunction

向作者/读者索取更多资源

Recently it was suggested that abnormal endothelial function may contribute to the pathophysiological changes observed in preeclampsia (PE). Both nitric oxide (NO) and endothelin-1 (ET-1) are vasoactive substances produced by endothelial cells. NO is a vasodilator and has been believed to be decreased in PE, ET-1 is a vasoconstrictor and has been reported to be increased in PE. We simultaneously measured NO metabolites and ET-1 in sera from women with PE and investigated the correlation of NO and ET-1 concentrations. We obtained serum samples from 11 healthy nonpregnant (NP) women, 16 normotensive pregnant (NTP) women and 17 women with PE. In this study, the serum ET-1 level was assayed by the ET-1 RIA system, and serum NO metabolites were assayed by measuring nitrite (NO2-) and nitrate (NO3-) simultaneously in an HPLC-Griess reaction system. There was a significant correlation between NOx (nitrite + nitrate) and ET-1 in sera from all 44 women (NP, NTP and PE groups) (p < 0.001). Nitrite and ET-1 in sera from each group were not significantly correlated. Nitrate and ET-1 in sera from the NP and NTP groups did not significantly correlate. However, there was a significant correlation between nitrate and ET-1 in sera from the PE group (p < 0.05). The serum ET-1 and nitrate concentration in the PE group was significantly higher than in the NP and NTP groups (p < 0.05 and p < 0.001, respectively). These findings suggest that increased production of nitrate in PE may contribute to homeostatic vasodilation against vasoconstriction caused by a higher ET-1 concentration. (C) 2000 Elsevier Science Inc, All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据